FGF14-AS1

Across TCGA pan-cancer cohorts, FGF14-AS1 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FGF14-AS1’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where FGF14-AS1 RNA is repressed in tumor relative to normal tissue. In most cancer types FGF14-AS1 is over-expressed in tumor, although a few such as UCEC and THCA show the opposite, repressed pattern.

UCEC, KIRP, and KIRC are the cancer types where FGF14-AS1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FGF14-AS1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	−0.128	.003	4	view →
KIRP	All	III,IV	+0.076	.032	2	view →
KIRC	All	All	+0.043	.029	2	view →
THCA	All	All	−0.069	.030	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

FGF14-AS1–UCEC

Open the UCEC breakdown →